Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bleiberg

Showing results (1-10 of 159) with videos related to

Pageof 16
Sort By:
Tumori|January 1, 1997
CPT-11 (irinotecan) in the treatment of colorectal cancer: a new mechanism of action for additional activityH Bleiberg
British Journal of Cancer|July 1, 1998
Oxaliplatin (L-OHP): a new reality in colorectal cancerH Bleiberg
Medecine & Chirurgie Digestives|January 1, 1980
[Therapeutic progress in digestive oncology. VII--Local treatment of hepatic metastases]H Bleiberg
Current Opinion in Oncology|August 1, 1991
Management of esophageal, gastric, pancreatic, and hepatobiliary neoplasmsH Bleiberg
European Journal of Cancer & Clinical Oncology|July 1, 1988
Identification of preneoplastic changesH Bleiberg
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
Colorectal cancer--is there an alternative to 5-FU?H Bleiberg
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
CPT-11 in gastrointestinal cancerH Bleiberg
Current Opinion in Oncology|July 11, 2000
A new class of antiemetics: the NK-1 receptor antagonistsH Bleiberg
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1990
The future of adjuvant treatment in gastrointestinal cancerH Bleiberg
Seminars in Oncology|February 1, 1996
Role of chemotherapy for advanced colorectal cancer: new opportunitiesH Bleiberg
Pageof 16

Showing results (1-10 of 159) with videos related to

Sort By:
Pageof 16
Tumori|January 1, 1997
CPT-11 (irinotecan) in the treatment of colorectal cancer: a new mechanism of action for additional activityH Bleiberg
British Journal of Cancer|July 1, 1998
Oxaliplatin (L-OHP): a new reality in colorectal cancerH Bleiberg
Medecine & Chirurgie Digestives|January 1, 1980
[Therapeutic progress in digestive oncology. VII--Local treatment of hepatic metastases]H Bleiberg
Current Opinion in Oncology|August 1, 1991
Management of esophageal, gastric, pancreatic, and hepatobiliary neoplasmsH Bleiberg
European Journal of Cancer & Clinical Oncology|July 1, 1988
Identification of preneoplastic changesH Bleiberg
European Journal of Cancer (Oxford, England : 1990)|April 1, 1997
Colorectal cancer--is there an alternative to 5-FU?H Bleiberg
European Journal of Cancer (Oxford, England : 1990)|August 17, 1999
CPT-11 in gastrointestinal cancerH Bleiberg
Current Opinion in Oncology|July 11, 2000
A new class of antiemetics: the NK-1 receptor antagonistsH Bleiberg
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|June 1, 1990
The future of adjuvant treatment in gastrointestinal cancerH Bleiberg
Seminars in Oncology|February 1, 1996
Role of chemotherapy for advanced colorectal cancer: new opportunitiesH Bleiberg
Pageof 16